NYSE · CI
Healthcare · Medical - Healthcare Plans
$278.88
Up+$1.21 (+0.44%)
Updated Aug 31, 2026, 7:33 AM
SID Score
6.6/10
Composite research score
Smart Money
47/100
Neutral
Price performance
1M range · 20 trading sessions · Daily adjusted prices
CI closed at $278.88 after 20 trading sessions, down 1.13% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 28, 2026 | $280.68 | $280.68 | $277.65 | $278.88 | 1.6M |
| Aug 27, 2026 | $277.79 | $281.80 | $276.31 | $277.67 | 1.23M |
| Aug 26, 2026 | $279.70 | $286.01 | $279.40 | $280.87 | 1.23M |
| Aug 25, 2026 | $278.87 | $279.55 | $276.25 | $279.32 | 1.64M |
| Aug 24, 2026 | $278.51 | $281.73 | $276.96 | $280.45 | 1.97M |
| Aug 21, 2026 | $274.81 | $279.39 | $274.25 | $277.51 | 2.06M |
| Aug 20, 2026 | $277.24 | $278.80 | $274.04 | $274.41 | 1.09M |
| Aug 19, 2026 | $279.61 | $282.745 | $276.91 | $277.45 | 1.13M |
| Aug 18, 2026 | $278.50 | $282.58 | $277.73 | $278.50 | 920.79K |
| Aug 17, 2026 | $280.00 | $280.12 | $274.61 | $275.33 | 893.51K |
| Aug 14, 2026 | $278.54 | $283.00 | $277.685 | $282.56 | 895.89K |
| Aug 13, 2026 | $278.59 | $280.3225 | $277.24 | $277.99 | 1.4M |
| Aug 12, 2026 | $272.82 | $279.07 | $272.46 | $277.41 | 1.53M |
| Aug 11, 2026 | $279.48 | $279.89 | $270.91 | $273.87 | 1.74M |
| Aug 10, 2026 | $282.54 | $285.74 | $277.58 | $278.40 | 1.46M |
| Aug 7, 2026 | $274.49 | $283.30 | $273.0301 | $282.49 | 2.29M |
| Aug 6, 2026 | $273.37 | $276.73 | $269.01 | $275.25 | 2.98M |
| Aug 5, 2026 | $268.24 | $272.52 | $263.11 | $270.50 | 4.64M |
| Aug 4, 2026 | $276.27 | $276.98 | $272.08 | $274.05 | 2.8M |
| Aug 3, 2026 | $279.05 | $283.83 | $276.71 | $282.06 | 1.79M |
The latest Smart Investors Daily articles mentioning CI.
CI research
Company profile and research snapshot.
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is with the Department of Defense (current contract through 2029), and it recently won a multiyear deal with top-tier insurer Centene. In health insurance and other benefits, Cigna primarily serves employers through self-funding arrangements, and the company operates mostly in the US with 17 million US and 2 million international medical members covered as of December 2024.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 4, 2026 | Jefferies | Hold | — |
| Aug 3, 2026 | Raymond James | Outperform | — |
| Jul 31, 2026 | Barclays | Equal-Weight | — |
| Jul 31, 2026 | Wells Fargo | Equal-Weight | — |
| Jul 31, 2026 | Guggenheim | Buy | — |
No generated briefing is available yet.
Benzinga · Aug 27, 2026
Cigna Group (NYSE:CI) has outperformed the market over the past 20 years by 1.25% on an annualized basis producing an average annual return of 10.49%. Currently, Cigna Group has a market capitalization of $73.46
Benzinga · Aug 26, 2026
By linking medical and supplemental health benefits, the new solution reduces administrative complexity and helps customers identify and use their available benefits. It also makes it easier to access cash benefits tied
Yahoo · Aug 23, 2026
Cigna Group stock reacts to TestMu Conference spotlight on AI and reliability Cigna Group (CI) is in focus after the company scheduled a presentation at the 5th TestMu Conference on August 19, 2026, featuring AI and automation engineering lead Nagarjun Adikesavan. The event highlights Cigna Group’s emphasis on quality and reliability in AI driven systems, which matters for investors who are watching how large health insurers apply automation to complex pharmacy and medical benefit...
Yahoo · Aug 23, 2026
Cigna Group stock has delivered a 44.4% gain over the past five years, yet the broader valuation checks still suggest the shares screen as undervalued at the recent price of US$277.51. With shorter term returns weaker, investors are left weighing a mixed share price history against a still supportive valuation read. Over five years, Cigna Group has returned 44.4%, which points to solid long term wealth creation despite more recent share price softness. Expectations for the company to keep...
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning CI.
